Showing results (141-150 of 460) with videos related to
Sort By:
Pageof 46
Elife|October 16, 2015
Reconstructing the in vivo dynamics of hematopoietic stem cells from telomere length distributionsBenjamin Werner, Fabian Beier, Sebastian Hummel, et al.Journal of Virology|August 13, 2010
Mutations in the stalk region of the measles virus hemagglutinin inhibit syncytium formation but not virus entryMatthew K Ennis, Chunling Hu, Shruthi K Naik, et al.Annals of Hematology|May 18, 2023
Relationship of paroxysmal nocturnal hemoglobinuria (PNH) granulocyte clone size to disease burden and risk of major vascular events in untreated patients: results from the International PNH RegistryDavid Dingli, Jaroslaw P Maciejewski, Loree Larratt, et al.Health and Quality of Life Outcomes|August 9, 2024
Patient-reported outcomes and daily activity assessed with a digital wearable device in patients with paroxysmal nocturnal hemoglobinuria treated with ravulizumab: REVEAL, a prospective, observational studyElizabeth A Griffiths, Jae S Min, Wei-Nchih Lee, et al.AJR. American Journal of Roentgenology|July 24, 2010
Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancerAlan R Penheiter, Troy R Wegman, Kelly L Classic, et al.Transfusion|February 17, 2025
Increasing use of CAR-T therapy occurs in conjunction with decreasing stem cell transplants with stable resource usage over a 6-year period: Resource utilization implicationsAswath P Chandrasekar, Margret A DiGuardo, Jeffrey L Winters, et al.Case Reports in Hematology|June 8, 2026
Paroxysmal Nocturnal Hemoglobinuria Presenting With Progressive Biventricular ThrombiJordan S Nunnelee, Garrett A Weber, Nicholas P Bergeron, et al.AJR. American Journal of Roentgenology|December 23, 2008
Quantitative molecular imaging of viral therapy for pancreatic cancer using an engineered measles virus expressing the sodium-iodide symporter reporter geneStephanie K Carlson, Kelly L Classic, Elizabeth M Hadac, et al.Blood|January 22, 2010
Stem cell transplantation in multiple myeloma: impact of response failure with thalidomide or lenalidomide inductionMorie A Gertz, Shaji Kumar, Martha Q Lacy, et al.Clinical Lymphoma & Myeloma|April 28, 2006
Cyclophosphamide mobilization does not improve outcome in patients receiving stem cell transplantation for multiple myelomaDavid Dingli, Grzegorz S Nowakowski, Angela Dispenzieri, et al.Pageof 46